CoChat

Constitutive ap‐1 dna binding and transactivating ability of malignant but not benign mouse epidermal cells

Domann, Frederick E., Levy, John P., Finch, Joanne S., Tim Bowden, G. · 1994 · Molecular Carcinogenesis
Cited by 71

The DOI matches its Crossref record.

Abstract

The mouse epidermal cell line 308 contains an activated Ha‐ras gene and forms benign papillomas when transplanted to the skin of athymic nude mice. A radiation‐associated malignant variant of this cell line, 308‐10Gy5, has been isolated and shown to form squamous cell carcinomas in nude mice. To further examine the molecular events involved in malignant conversion of 308‐10Gy5, we assessed the activator protein‐1 (AP‐1) binding and transactivating ability of 308 and 308‐10Gy5. In nuclear protein extracts of 308, AP‐1 sequence‐specific binding to an oligonucleotide containing a single high‐affinity AP‐1 binding site was induced by the tumor promoter 12‐O‐tetradecanoylphorbol‐13‐acetate, as determined by gel shift analysis. Nuclear extracts of 308‐10Gy5 bound to the AP‐1 oligonucleotide without treatment with tumor promoters. Not only was sequence‐specific AP‐1 DNA binding constitutively active in malignant versus benign tumor cells, but so was transactivation of a unique AP‐1‐responsive chloramphenicol acetyltransferase reporter construct, pTiCTaK. Constitutive transactivation of this AP‐1–responsive reporter construct was observed in the malignant but not the benign tumor cells. Furthermore, steady‐state transcript levels of the tumor‐associated AP‐1–responsive genes stromelysin, urokinase‐type plasminogen activator, c‐jun, and c‐fos were higher in malignant 308‐10Gy5 cells than in benign 308 cells. These results suggest that acquisition of constitutive AP‐1 DNA binding and transactivation can result in sustained deregulation of gene expression. While malignant progression in keratinocytes is probably not due solely to the acquisition of constitutive cellular AP‐1 activity, the effect of deregulated expression of AP‐1–regulated genes, especially basement membrane–degrading enzymes, may be functionally related to malignant conversion. © 1994 Wiley‐Liss, Inc.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/mc.2940090202

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 71

Metadata

Authors
Domann, F. E., Levy, J. P., Finch, J. S., & Tim Bowden, G.
Venue
Molecular Carcinogenesis
Publisher
Wiley
Published
1994-02
Volume
9
Issue
2
Pages
61-66
ISSN
  • 0899-1987 (ISSN-L)
  • 1098-2744
OpenAlex
W2084960544
Cited by
71
References
0
FWCI
1.59
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Constitutive ap‐1 dna binding and transactivating ability of malignant but not benign mouse epidermal cells. https://app.cochat.ai/papers/10.1002/mc.2940090202
The paper
Domann, F. E., Levy, J. P., Finch, J. S., & Tim Bowden, G. (1994). Constitutive ap‐1 dna binding and transactivating ability of malignant but not benign mouse epidermal cells. Molecular Carcinogenesis. https://doi.org/10.1002/mc.2940090202

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.